These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4060879)

  • 21. [Blood sialic acids in atherosclerosis].
    Gracheva EV; Golovanova NK; Kononova OI; Kozlov SG; Prokazova NV; Liakishev AA
    Biokhimiia; 1995 May; 60(5):718-22. PubMed ID: 7662798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum sialic acid level (SSAL) in patients with cancer or tuberculosis of the lung (author's transl)].
    Wang FL; Wang YQ; Zhang ZY; Zhao C
    Zhonghua Zhong Liu Za Zhi; 1981 Aug; 3(3):177-80. PubMed ID: 7338143
    [No Abstract]   [Full Text] [Related]  

  • 23. [The diagnostic value of the assay of lactate dehydrogenese combined with other tumor markers in ovarian cancer].
    Tang BJ; Li L; Xu J
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):336-9, 381. PubMed ID: 8001406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Level of lipid-bound sialic acids in blood from brain tumor patients].
    Popova GM; Promyslov MSh
    Vopr Med Khim; 1995; 41(1):43-5. PubMed ID: 7771092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A
    Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Magnetic resonance imaging (MRI) in the diagnosis of recurrences of ovarian cancer in the small pelvis].
    Bulanova IM; Bulanova TV; Burenchev DV
    Vestn Rentgenol Radiol; 2005; (6):47-54. PubMed ID: 16898094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in serum fucose and sialic acid contents and the course of malignant ovarian neoplasms].
    Jaskulska T; Markowska J; Manyś G; Branowski M
    Nowotwory; 1983; 33(3):203-8. PubMed ID: 6664892
    [No Abstract]   [Full Text] [Related]  

  • 28. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
    Hefler L; Tempfer C; Heinze G; Mayerhofer K; Breitenecker G; Leodolter S; Reinthaller A; Kainz C
    Br J Cancer; 1999 Nov; 81(5):855-9. PubMed ID: 10555758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical parameters in the comprehensive diagnosis of lung cancer].
    Liubimova NV; Khaĭlenko VA; Kushlinskiĭ NE; Davydov MI
    Vopr Onkol; 1994; 40(4-6):156-61. PubMed ID: 7785236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipid-bound sialic acids in the diagnosis of malignant neoplasms of the lungs and stomach].
    Surina AG; Tokarskaia ZB
    Lab Delo; 1986; (8):470-3. PubMed ID: 2429050
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor marker trends in asymptomatic women at risk for ovarian cancer: relevance for ovarian cancer screening.
    Cane P; Azen C; Lopez E; Platt LD; Karlan BY
    Gynecol Oncol; 1995 May; 57(2):240-5. PubMed ID: 7729742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Total and lipid-bound sialic acids in the blood in primary and secondary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Lupanov VP; Liakishev AA; Titov VN
    Ter Arkh; 1997; 69(1):23-5. PubMed ID: 9163043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
    Patel PS; Rawal GN; Balar DB
    Gynecol Oncol; 1993 Sep; 50(3):294-9. PubMed ID: 8406190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of lipid bound sialic acid in sera of cancer patients.
    Shanmugam V; Nagrajan B
    Indian J Cancer; 1986 Sep; 23(3):173-7. PubMed ID: 3623602
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum haptoglobin in patients with ovarian malignancies.
    Mueller WK; Handschumacher R; Wade ME
    Obstet Gynecol; 1971 Sep; 38(3):427-35. PubMed ID: 4999312
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum sialic acid in cases of malignancy.
    Sharma RC; Tyagi SP; Sibghatuallah ; Tyagi N
    Indian J Pathol Microbiol; 1987 Jul; 30(3):317-25. PubMed ID: 3449461
    [No Abstract]   [Full Text] [Related]  

  • 37. [Frequency of recurrence and repeated development of ovarian tumors after conservative operations].
    Utkin IuK
    Vopr Onkol; 1981; 27(3):29-32. PubMed ID: 7222519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness and potential pitfalls of sialic acid determination in sera of patients with ovarian tumors.
    Berra B; Rapelli S; Monticelli G; Fighetti MA; Della Mea I; Raspagliesi F; Di Re E; Ringhini R; Bombardieri E
    Int J Biol Markers; 1986; 1(1):39-46. PubMed ID: 3693972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of lipid-bound sialic acid and total sialic acids in the blood].
    Inoue H
    Rinsho Byori; 1983 Mar; Suppl 54():203-7. PubMed ID: 6887579
    [No Abstract]   [Full Text] [Related]  

  • 40. [Detection of serum sialic acid in three kinds of malignant tumor and its clinical significance].
    Liang XH; Liang XM; Yi B
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):65-6. PubMed ID: 12934403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.